In Vivo Models
Resources
Home > Resources > Zebrafish Resource Center
Since we expanded our genome editing expertise to include the creation of zebrafish models, we are fortunate to have worked with over one hundred clients to deliver custom solutions to help solve their gene editing challenges. During this process we have learned a lot about zebrafish genome editing, which has driven us to improve our techniques and workflows. Along the way we have collected useful tips and tricks in many aspects of developing zebrafish models, from zebrafish husbandry to genome editing techniques. We are pleased to share everything we have learned with you!
If you are new to zebrafish research, feel free to check out our Zebrafish 101 White Paper which discusses the attributes of zebrafish, their advantages and limitations, and how they are currently being used in research to answer the question: is a zebrafish model right for my research?
We compiled the most relevant and influential publications since 2015 based on the most commonly studied diseases using zebrafish as a model.
Select examples of zebrafish discoveries leading to clinical trials.
In these interveiws, zebrafish researchers share their experiences and advice for using zebrafish as a research tool.
Have you ever wanted to learn more about how we care for our zebrafish, how to start your own rack, what feed is best.
Technologies such as CRISPR and next-generation sequencing, have revolutionized disease modelling, particularly in zebrafish.
A collection of articles and reviews that discusses a variety of zebrafish genome editing methodologies.
A list of common terms used in zebrafish genome editing.
Using the search tool to find a usable model for studying your gene of interest.
The InVivo Biosystems Newsletter is delivered to your inbox bi-weekly,
giving you all of the latest company updates, industry news, and more.
An expert in CRISPR genome editing, InVivo Biosystems creates custom genome-edited C. elegans and zebrafish models to enable aging, developmental, and disease studies. Our unique in vivo platforms and technologies bridge the gap between cells and mice.
